American Shared Hospital Services Company Profile
NYSE: AMSHealth CareMedical SpecialitiesUSD
At close: Nov 20, 3:40 PM ET · Delayed 15 min
American Shared Hospital Services at a glance
American Shared Hospital Services (NYSE: AMS) is a Medical Specialities company in the Health Care sector headquartered in San Francisco, CA. American Shared Hospital Services is led by Mr. Craig K. Tagawa and employs about 82 people. The company's shares have traded publicly since 1988.
At a market capitalization of $6.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0000744825, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does American Shared Hospital Services do?
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
Business description based on the company's public filings.
Company information
- Legal name
- American Shared Hospital Services
- Ticker
- NYSE: AMS
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Craig K. Tagawa
- Employees
- 82
- Headquarters
- 601 Montgomery Street, San Francisco, CA, United States
- Phone
- 415 788 5300
- Website
- ashs.com
- IPO year
- 1988
- Market cap
- $6.81M
- SEC CIK
- 0000744825
- Latest annual report
- 10-K · Mar 31, 2026
Companies similar to American Shared Hospital Services
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACONAclarion Inc. | 1.22 | -13.92% | $3.52M | vs AMS |
| MDXHMDxHealth SA | 0.1074 | -8.52% | $10.25M | vs AMS |
| ADVBAdvanced Biomed Inc. | 1.65 | -5.71% | $2.73M | vs AMS |
| BGLCBioNexus Gene Lab Corp | 0.68 | 0.00% | $1.99M | vs AMS |
| SERASera Prognostics Inc. Class A | 1.81 | -4.23% | $71.98M | vs AMS |
| BDSXBiodesix Inc. | 7.56 | -8.92% | $83.83M | vs AMS |
| XGNExagen Inc. | 3.61 | -5.00% | $92.10M | vs AMS |
| KEQUKewaunee Scientific Corporation | 33.55 | -2.75% | $97.14M | vs AMS |